All News

Breast cancer and melanoma survivor shares coping strategies for the holidays.

The FDA has granted a priority review to a new drug application (NDA) for apalutamide (ARN-509) for the treatment of patients with nonmetastatic castration-resistant prostate cancer (CRPC), according to Janssen Biotech, the manufacturer of the next-generation oral androgen receptor inhibitor.

Julia Nangia, M.D., assistant professor at Baylor College of Medicine, discusses the impact that chemotherapy-related hair loss can have on patients with breast cancer.

Blue Faery, the Adrienne Wilson Liver Cancer Association, is a nonprofit corporation founded in 2002, with the intent to prevent, treat and cure primary liver cancer – particularly HCC – through research, education and advocacy. Its name, inspired by Adrienne, has a unique background.

How often do you pause for reflection?

The FDA has approved Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy as an adjuvant treatment for patients with HER2-positive early breast cancer at high risk for recurrence, based on findings from the APHINITY trial.

The FDA has approved Opdivo (nivolumab) as an adjuvant treatment for patients with completely resected melanoma with lymph node involvement or metastatic disease, based on findings from the phase 3 CheckMate-238 trial.

FINANCIAL TOXICITY IS AN increasingly used term that describes the multiple negative consequences of medical care costs on the patient, whether it be for cancer or another serious illness.

Optune is a method of treatment where adhesive patches are applied to the patient’s scalp. The patch transductors deliver low-intensity electric fields – called Tumor Treating Fields – that stop the growth and division of GBM cells.

Our cultural tendency to try to draw bright lines when it comes to the cost of health care relies on hindsight to criticize doctors for their lack of foresight. But it is only hindsight, as we all know, that is 20/20.

Cancer-free but at risk, one previvor felt guilty for receiving medical attention.

My last point of training was going to the San Antonio Breast Cancer Symposium (SABCS), which takes place the first week of December. It’s the biggest breast cancer symposium in the country and a chance for doctors, researchers and advocates to get together to hear the latest updates in research and clinical trials.

The FDA has approved Bosulif (bosutinib) as a first-line treatment for patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML), based on findings from the phase 3 BFORE trial.

Cabometyx (cabozantinib) was granted approval by the Food and Drug Administration (FDA) for previously untreated patients who have advanced renal cell carcinoma (RCC).

Of every complication caused from cancer and its treatments, nausea has been the worst for my sister. It has caused pain, discomfort and was the number one reason she returned to the emergency room. No matter what medications were dosed, whether it was orally or by IV, or how much they gave to her, so often, nothing ever seemed to work.

Should I be planning big, celebratory trips or my funeral? My fears may not be rational, but they're real.

Why December is a good month to bug myself – and anyone in the Cancer Club – about changing it up.

Recent findings that the most common kind of ovarian cancer may start in the fallopian tubes could have implications for the prevention, diagnosis and treatment of the disease subtype.

Join us today, Dec. 19, for our year-end #CureConnect tweet chat, where we will be diving into what our readers saw as the most important updates of the year. Maybe people were intrigued by the correlation between viruses and cancer, or maybe improving cancer survivorship was key this year.

Many patients with cancer choose to use homeopathic therapies either in addition to, or in lieu of traditional treatments. However, since these agents don’t go through the same FDA approval process as typical drugs, patients may be subject to harmful effects.

A free online pilot program helps people with cancer and their partners work through sexual health and fertility obstacles.

While the holidays can sometimes be a challenging time, there are always gifts to be found.

An easier application process could make experimental drugs more accessible to patients in need — outside the realm of clinical trials.

There are many ways to meditate, but I have learned there are some basic ways to support and promote healing by connecting with breath and mind. This aids in fighting feelings such as anxiety and depression when going through a cancer diagnosis.

Frontline Tagrisso (osimertinib) was granted a priority review to a supplemental new drug application (sNDA) by the Food and Drug Administration (FDA) to treat patients with non-small cell lung cancer (NSCLC) whose tumors have EGFR mutations (exon 19 deletions or exon 21 [L858R] substitution mutations).

Setting resolutions for the New Year is a common practice but one breast cancer survivor has a different perspective on how hers should look for 2018.

I will remember my students' act of kindness forever.

Breast cancer and melanoma survivor shares ways to cope with fear of recurrence and cancer worries.

Patients with blood cancers typically value time spent at home in their end-of-life care, however, health care systemts do not always prioritize this in their own quality measures.